Breaking News Instant updates and real-time market news.

LYV

Live Nation

$48.15

-0.53 (-1.09%)

17:46
08/17/18
08/17
17:46
08/17/18
17:46

Live Nation CFO discloses sale of 40K shares of common stock

Live Nation CFO Elizabeth Willard disclosed in a filing that she had sold 40,000 shares of company stock at an average price of $48.71 per share on August 15 and 16. The total transaction value was $1.95M.

LYV Live Nation
$48.15

-0.53 (-1.09%)

07/30/18
SPHN
07/30/18
NO CHANGE
Target $60
SPHN
Overweight
Live Nation price target raised to $60 from $50 at Stephens
Stephens analyst Kyle Evans said he expects solid results from Live Nation (LYV) for the rest of 2018 and sees few fundamental risks. However, he notes he is becoming "increasingly valuation sensitive" given the recent 35% run-up in the stock, which he attributes to its solid results, suspicion that the company is "intentionally under-earning" and new speculation that the company could be acquired by Sirius XM (SIRI). Evans keeps an Overweight rating on Live Nation with an increased price target of $60.
07/24/18
07/24/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. MOSAIC DOUBLE UPGRADED: BofA Merrill Lynch double upgraded Mosaic (MOS) to Buy from Underperform and raised its price target to $35 from $24. Analyst Steve Byrne said he believes 2018 will mark a bottom in global phosphate utilization rates and now believes there is more upside risk to consensus estimates as the cycle improves. Mosiac was higher by 3.5% approaching midday. BTIG SAYS BUY LIVE NATION: BTIG analyst Brandon Ross upgraded Live Nation (LYV) to Buy from Neutral with a $60 price target, saying he is now more convinced that the company will outperform expectations amid inflecting growth with an added possibility of M&A. Despite the tough comparisons, Ross notes that Live Nation should "handily" top operating income consensus in FY18 and going forward, having built an "insurmountable" competitive float in U.S. markets, and that its mid-teens EBITDA growth is "the new normal". WHIRLPOOL CUT AFTER EARNINGS: Longbow analyst David MacGregor downgraded Whirlpool (WHR) to Neutral from Buy after the company reported Q2 earnings that missed the firm's "Street low" estimate of $3.55, calling its quarter "disappointing across most dimensions of the business." Expectations for a recovery in the EMEA region are being pushed out to beyond 2020, noted MacGregor, who is waiting for after the company's earnings call to reassess his view of its earnings prospects. MIZUHO CALLS EOG 'THE APPLE OF OIL': Mizuho analyst Paul Sankey started EOG Resources (EOG) with a Buy rating and $173 price target, calling EOG -- his top pick in the group -- the Apple (AAPL) of oil. EOG has been a pioneer in unconventional oil development in the U.S. and its technology-driven, innovation-focused approach will continue to drive peer-leading rates of return and oil growth, the analyst contended. EOG was up 2.6% near midday. SUSQUEHANNA RAISES ALPHABET TARGET TO $1,500: After Alphabet's (GOOG, GOOGL) Q2 earnings report on Monday night, many analyst firms raised their price targets on the name. The highest of those targets was from Susquehanna analyst Shyam Patil, who raised his price target on Alphabet to $1,500 from $1,250. The analyst cited the "impressive" sites revenue growth acceleration, which he sees as evidence that the secular momentum for the ads business remains in place. Patil reiterated his Positive rating on Alphabet shares. Class A shares of Google's parent were up over 4% to $1,260.80 at time of writing.
07/24/18
07/24/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Mosaic (MOS) double upgraded to Buy from Underperform at BofA/Merrill with analyst Steve Byrne saying he believes 2018 will mark a bottom in global phosphate utilization rates and now believes there is more upside risk to consensus estimates as the cycle improves. 2. Live Nation (LYV) upgraded to Buy from Neutral at BTIG with analyst Brandon Ross saying he is now more convinced that the company will outperform expectations amid inflecting growth rate with an added possibility of M&A. 3. Infinera (INFN) upgraded to Outperform from Market Perform at Northland with analyst Tim Savageaux saying the calculus of his March downgrade changes with the acquisition of Coriant, giving the company a double-digit market share in 100G+ optical systems. 4. Baker Hughes (BHGE) upgraded to Buy from Hold at SunTrust with analyst Ken Sill saying the EPS miss was due to higher interest expense and taxes, as well as an asset charge that is "hopefully non-recurring." 5. Werner (WERN) upgraded to Neutral from Underperform at BofA/Merrill with analyst Ken Hoexter saying Q2 freight demand in One way Truckload was much stronger than normal and revenue per load mile was up 13.3% year-over-year, the strongest level in more than 20 years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/24/18
GSCO
07/24/18
NO CHANGE
Target $56
GSCO
Buy
Live Nation estimates raised ahead of report, target to $56 at Goldman Sachs
Goldman Sachs analyst Drew Borst raised Live Nation's Q2 earnings estimates ahead of the July 26 report to reflect an increase in Ticketing and Sponsorship/Advertising. Borst's Q2 earnings estimate increases to $2.83B from $2.825B and AOI moves up to $251M from $246M. The analyst rates Live Nation a Buy with a $56 price target, up from $50.

TODAY'S FREE FLY STORIES

RETA

Reata Pharmaceuticals

$90.96

3.4 (3.88%)

07:21
09/25/18
09/25
07:21
09/25/18
07:21
Conference/Events
Reata Pharmaceuticals to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 01

    Oct

OIBR

Oi S.A.

$0.00

(0.00%)

07:21
09/25/18
09/25
07:21
09/25/18
07:21
Downgrade
Oi S.A. rating change  »

Oi S.A. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RETA

Reata Pharmaceuticals

$90.96

3.4 (3.88%)

07:21
09/25/18
09/25
07:21
09/25/18
07:21
Hot Stocks
Reata Pharmaceuticals T1D CKD cohorts of PHOENIX trial meet endpoint »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

SB

Safe Bulkers

$2.72

-0.01 (-0.37%)

07:19
09/25/18
09/25
07:19
09/25/18
07:19
Conference/Events
Safe Bulkers management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 08

    Oct

HEP

Holly Energy Partners

$32.95

0.43 (1.32%)

07:19
09/25/18
09/25
07:19
09/25/18
07:19
Downgrade
Holly Energy Partners rating change  »

Holly Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

KORS

Michael Kors

$66.71

-5.96 (-8.20%)

07:18
09/25/18
09/25
07:18
09/25/18
07:18
Hot Stocks
Michael Kors sees opportunity to grow revenues to $8B in long-term »

In slides being presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$73.59

-0.11 (-0.15%)

, AAPL

Apple

$220.79

3.14 (1.44%)

07:17
09/25/18
09/25
07:17
09/25/18
07:17
Recommendations
Qualcomm, Apple analyst commentary  »

Qualcomm estimates…

QCOM

Qualcomm

$73.59

-0.11 (-0.15%)

AAPL

Apple

$220.79

3.14 (1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

CLX

Clorox

$149.98

-2.34 (-1.54%)

07:17
09/25/18
09/25
07:17
09/25/18
07:17
Upgrade
Clorox rating change  »

Clorox upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVAX

Novavax

$1.84

0.24 (15.00%)

07:17
09/25/18
09/25
07:17
09/25/18
07:17
Hot Stocks
Novavax initiates Phase 2 trial of NanoFlu in older adults »

Novavax announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 27

    Nov

KORS

Michael Kors

$66.71

-5.96 (-8.20%)

07:17
09/25/18
09/25
07:17
09/25/18
07:17
Hot Stocks
Breaking Hot Stocks news story on Michael Kors »

Michael Kors trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSI

Motorola Solutions

$128.96

0.54 (0.42%)

07:16
09/25/18
09/25
07:16
09/25/18
07:16
Recommendations
Motorola Solutions analyst commentary  »

Motorola Solutions price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$368.04

-3.84 (-1.03%)

, LMT

Lockheed Martin

$337.65

-0.13 (-0.04%)

07:16
09/25/18
09/25
07:16
09/25/18
07:16
Hot Stocks
Boeing beats Lockheed's Sikorsky, Sierra Nevada for Air Force contract »

Shares of Boeing (BA) are…

BA

Boeing

$368.04

-3.84 (-1.03%)

LMT

Lockheed Martin

$337.65

-0.13 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

CURO

Curo Group

$30.59

-0.48 (-1.54%)

07:15
09/25/18
09/25
07:15
09/25/18
07:15
Recommendations
Curo Group analyst commentary  »

Curo Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ALXN

Alexion

$128.49

6.52 (5.35%)

07:15
09/25/18
09/25
07:15
09/25/18
07:15
Recommendations
Alexion analyst commentary  »

Alexion price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

TGTX

TG Therapeutics

$9.25

0.2 (2.21%)

07:15
09/25/18
09/25
07:15
09/25/18
07:15
Hot Stocks
DSMB says TG Therapeutics UNITY-CLL trial ORR analysis can not be conducted »

TG Therapeutics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

CPRI

Capri Holdings

$0.00

(0.00%)

, KORS

Michael Kors

$66.71

-5.96 (-8.20%)

07:14
09/25/18
09/25
07:14
09/25/18
07:14
Hot Stocks
Donatella, Santo, Allegra Versace to become shareholders in Capri Holdings »

"This is a very…

CPRI

Capri Holdings

$0.00

(0.00%)

KORS

Michael Kors

$66.71

-5.96 (-8.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBOW

SilverBow Resources

$28.84

0.37 (1.30%)

07:13
09/25/18
09/25
07:13
09/25/18
07:13
Downgrade
SilverBow Resources rating change  »

SilverBow Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

BCPC

Balchem

$114.95

-1.11 (-0.96%)

07:11
09/25/18
09/25
07:11
09/25/18
07:11
Initiation
Balchem initiated  »

Balchem initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOTS

Motus GI Holdings

$5.13

-0.12 (-2.29%)

07:11
09/25/18
09/25
07:11
09/25/18
07:11
Hot Stocks
Motus GI Holdings appoints Timothy Moran as CEO »

Motus GI Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

KORS

Michael Kors

$66.71

-5.96 (-8.20%)

07:11
09/25/18
09/25
07:11
09/25/18
07:11
Hot Stocks
Breaking Hot Stocks news story on Michael Kors »

Michael Kors trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BILI

Bilibili

$11.95

-0.52 (-4.17%)

, DISCA

Discovery

$31.91

0.12 (0.38%)

07:10
09/25/18
09/25
07:10
09/25/18
07:10
Hot Stocks
Bilibili announces content partnership with Discovery for platform in China »

Bilibili (BILI) announced…

BILI

Bilibili

$11.95

-0.52 (-4.17%)

DISCA

Discovery

$31.91

0.12 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KORS

Michael Kors

$66.71

-5.96 (-8.20%)

07:10
09/25/18
09/25
07:10
09/25/18
07:10
Hot Stocks
Michael Kors sees Versace acquisition dilutive in high-single digits in FY20 »

Michael Kors believes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$12.40

9.4 (313.33%)

, TEVA

Teva

$23.87

-0.48 (-1.97%)

07:10
09/25/18
09/25
07:10
09/25/18
07:10
Recommendations
Amarin, Teva analyst commentary  »

Citi more than triples…

AMRN

Amarin

$12.40

9.4 (313.33%)

TEVA

Teva

$23.87

-0.48 (-1.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

MANU

Manchester United

$23.95

-0.25 (-1.03%)

07:08
09/25/18
09/25
07:08
09/25/18
07:08
Earnings
Manchester United sees FY19 revenue GBP615M-GBP630M »

Sees adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

KORS

Michael Kors

$66.71

-5.96 (-8.20%)

, CPRI

Capri Holdings

$0.00

(0.00%)

07:08
09/25/18
09/25
07:08
09/25/18
07:08
Hot Stocks
Michael Kors to be renamed Capri Holdings »

Capri Holdings (CPRI) is…

KORS

Michael Kors

$66.71

-5.96 (-8.20%)

CPRI

Capri Holdings

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.